Profile data is unavailable for this security.
About the company
Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
- Revenue in USD (TTM)770.01m
- Net income in USD-141.45m
- Incorporated2008
- Employees2.40k
- LocationTandem Diabetes Care Inc12400 High Bluff DriveSAN DIEGO 92130United StatesUSA
- Phone+1 (858) 366-6900
- Fax+1 (302) 636-5454
- Websitehttps://www.tandemdiabetes.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Conmed Corp | 1.26bn | 82.35m | 2.27bn | 4.00k | 28.07 | 2.65 | 14.69 | 1.80 | 2.62 | 2.62 | 40.12 | 27.76 | 0.545 | 1.73 | 5.55 | 315,387.00 | 3.56 | 0.8972 | 4.10 | 1.02 | 54.92 | 54.95 | 6.53 | 1.65 | 1.08 | 3.65 | 0.5369 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Patterson Companies, Inc. | 6.57bn | 185.93m | 2.32bn | 7.60k | 13.19 | 2.36 | 8.46 | 0.3525 | 2.00 | 2.00 | 70.16 | 11.16 | 2.27 | 6.58 | 12.82 | 864,246.30 | 6.42 | 1.13 | 11.05 | 1.81 | 21.01 | 20.98 | 2.82 | 0.5157 | 0.7473 | 14.91 | 0.389 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
Quidelortho Corp | 2.86bn | -1.76bn | 2.33bn | 7.10k | -- | 0.7038 | -- | 0.8153 | -26.38 | -26.38 | 42.82 | 49.52 | 0.3696 | 2.67 | 8.92 | 403,197.20 | -22.79 | 11.34 | -25.57 | 12.91 | 48.13 | 62.71 | -61.65 | 20.93 | 0.807 | 0.8786 | 0.4207 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
10X Genomics Inc | 625.45m | -264.30m | 2.38bn | 1.26k | -- | 3.30 | -- | 3.80 | -2.24 | -2.24 | 5.30 | 6.01 | 0.6458 | 2.67 | 7.39 | 496,781.60 | -27.29 | -25.52 | -30.80 | -29.05 | 64.62 | 75.88 | -42.26 | -48.53 | 4.45 | -- | 0.00 | -- | 19.81 | 33.43 | -53.67 | -- | 49.15 | -- |
Evolent Health Inc | 2.18bn | -141.23m | 2.42bn | 4.70k | -- | 2.28 | -- | 1.11 | -1.25 | -1.25 | 19.28 | 10.72 | 0.8316 | -- | 6.30 | 462,948.70 | -4.22 | -9.60 | -5.36 | -12.59 | 20.56 | 24.50 | -5.07 | -13.66 | -- | -0.0548 | 0.3272 | -- | 45.26 | 25.65 | -660.71 | -- | -6.18 | -- |
UFP Technologies Inc | 407.33m | 47.88m | 2.43bn | 3.09k | 51.04 | 8.24 | 40.84 | 5.97 | 6.21 | 6.21 | 52.82 | 38.46 | 1.02 | 4.50 | 6.71 | 131,693.20 | 11.99 | 9.69 | 13.80 | 10.95 | 27.89 | 26.33 | 11.75 | 10.14 | 1.46 | 17.87 | 0.1039 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
Myriad Genetics, Inc. | 774.20m | -234.60m | 2.45bn | 2.70k | -- | 3.23 | -- | 3.17 | -2.82 | -2.82 | 9.11 | 8.40 | 0.6792 | 10.41 | 6.53 | 286,740.80 | -20.58 | -- | -23.57 | -- | 68.79 | -- | -30.30 | -- | 1.82 | -225.20 | 0.0485 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
Integra Lifesciences Holdings Corp | 1.53bn | 40.23m | 2.49bn | 3.95k | 62.32 | 1.56 | 15.28 | 1.63 | 0.5079 | 0.5079 | 19.32 | 20.29 | 0.3912 | 1.56 | 6.06 | 387,632.80 | 1.03 | 3.33 | 1.11 | 3.68 | 61.48 | 63.67 | 2.63 | 7.99 | 3.35 | 6.66 | 0.5374 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
Enovis Corp | 1.82bn | -103.33m | 2.60bn | 6.55k | -- | 0.7855 | 19.16 | 1.43 | -1.89 | -1.50 | 33.29 | 60.33 | 0.3717 | 1.49 | 5.49 | 277,452.20 | -2.10 | -0.3569 | -2.32 | -0.41 | 58.12 | 48.19 | -5.66 | -1.06 | 1.03 | 0.9243 | 0.2879 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
LivaNova PLC | 1.19bn | -31.77m | 2.95bn | 2.90k | -- | 2.41 | 175.08 | 2.49 | -0.5911 | -0.5911 | 21.89 | 22.56 | 0.4985 | 2.57 | 6.11 | 408,634.10 | -1.33 | -6.01 | -1.54 | -7.42 | 67.89 | 66.99 | -2.67 | -13.56 | 2.71 | 2.52 | 0.3383 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Tandem Diabetes Care Inc | 770.01m | -141.45m | 2.95bn | 2.40k | -- | 12.12 | -- | 3.83 | -2.17 | -2.17 | 11.82 | 3.76 | 0.8126 | 2.74 | 8.35 | 320,837.10 | -14.93 | -10.08 | -18.48 | -12.23 | 49.28 | 51.77 | -18.37 | -11.59 | 3.01 | -- | 0.5884 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Envista Holdings Corp | 2.56bn | -120.40m | 2.95bn | 12.80k | -- | 0.7133 | 270.87 | 1.15 | -0.713 | -0.713 | 14.72 | 24.09 | 0.3904 | 3.89 | 6.29 | 200,226.60 | -1.83 | 1.94 | -2.15 | 2.34 | 56.35 | 57.65 | -4.70 | 5.29 | 1.93 | 5.09 | 0.2667 | 0.00 | -0.1012 | -2.04 | -142.10 | -- | -4.22 | -- |
ICU Medical Inc | 2.26bn | -59.31m | 3.12bn | 14.00k | -- | 1.51 | 18.30 | 1.38 | -2.46 | -2.46 | 93.27 | 84.87 | 0.5154 | 2.12 | 15.86 | 161,223.70 | -1.35 | 1.46 | -1.51 | 1.65 | 32.48 | 34.11 | -2.63 | 2.23 | 1.09 | 0.4817 | 0.4393 | 0.00 | -0.9154 | 10.04 | 60.08 | -- | -1.45 | -- |
Irhythm Technologies Inc | 513.17m | -129.96m | 3.15bn | 2.00k | -- | 34.85 | -- | 6.13 | -4.22 | -4.22 | 16.71 | 2.90 | 0.7709 | 10.85 | 7.37 | 256,587.00 | -19.52 | -21.92 | -22.55 | -26.77 | 66.96 | 69.39 | -25.33 | -25.75 | 6.95 | -18.44 | 0.877 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
Inari Medical Inc | 520.66m | -23.62m | 3.41bn | 1.30k | -- | 7.60 | -- | 6.55 | -0.409 | -0.409 | 8.95 | 7.71 | 0.8913 | 1.58 | 7.75 | 400,506.90 | -4.04 | -0.5941 | -4.57 | -0.6696 | 87.67 | 89.06 | -4.54 | -0.6295 | 2.19 | -- | 0.00 | -- | 28.73 | 135.40 | 94.41 | -- | 52.46 | -- |
Axonics Inc | 387.14m | -15.95m | 3.47bn | 797.00 | -- | 5.53 | -- | 8.96 | -0.3134 | -0.3134 | 7.76 | 12.29 | 0.5606 | 1.20 | 8.53 | 485,744.00 | -2.31 | -12.67 | -2.52 | -13.76 | 75.25 | 70.04 | -4.12 | -29.68 | 8.04 | -- | 0.00 | -- | 33.86 | 249.06 | 89.80 | -- | 23.65 | -- |
Holder | Shares | % Held |
---|---|---|
BlackRock Fund Advisorsas of 31 Mar 2024 | 8.09m | 12.53% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 6.96m | 10.78% |
Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 3.67m | 5.68% |
Marshall Wace LLPas of 31 Mar 2024 | 3.12m | 4.83% |
ArrowMark Colorado Holdings LLCas of 31 Mar 2024 | 2.93m | 4.54% |
Jennison Associates LLCas of 31 Mar 2024 | 2.56m | 3.96% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 2.24m | 3.47% |
Janus Henderson Investors US LLCas of 31 Mar 2024 | 2.17m | 3.36% |
Bellevue Asset Management AGas of 31 Mar 2024 | 2.03m | 3.15% |
Champlain Investment Partners LLCas of 31 Mar 2024 | 1.51m | 2.34% |